No Data
Cosmos Health Will Not Proceed With Offering Under Form S-1
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
Cosmos Health Advances Cancer Treatment Innovation With Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
Cosmos Health Strengthens Management Team With the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order From Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility
Cosmos Health Receives $578,460 Initial Purchase Order From Al Rabwa International for Sky Premium Life Food Supplements in Qatar
